Fidelity Investments’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Fidelity Investments’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$7	–	5774
2023 Q3	$7	Buy	+2	New	+$9	﹤0.01%	5210
2022 Q4	–	Sell	-70	Closed	-$1K	–	5705
2022 Q3	$1K	Buy	70 +61	+678%	+$2.14K	﹤0.01%	4793
2022 Q2	$0	Sell	9 -13	-59%	-$968	﹤0.01%	5703
2022 Q1	$3K	Buy	+22	New	+$3.21K	﹤0.01%	4615
2021 Q3	–	Sell	-2	Closed	-$1K	–	5299
2021 Q2	$1K	Buy	+2	New	+$1.07K	﹤0.01%	4152
2020 Q3	–	Sell	-1	Closed	–	–	4119
2020 Q2	$0	Buy	+1	New	+$166	﹤0.01%	4344
2013 Q4	–	Sell	-972	Closed	-$2.19M	–	2709
2013 Q3	$2.19M	Buy	+972	New	+$1.88M	﹤0.01%	2329

Other funds holding AMPE

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments's AMPE Position: Q4 2023 in Review

Fidelity Investments sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2023, closing a stake of 2 shares — an estimated $7 sold.

Fidelity Investments first reported a position in AMPE in Q3 2013 and held it in 7 quarters. The position peaked at $2.19M in Q3 2013. 29 funds tracked by Wall St. Rank hold AMPE as of Q4 2023.

Fidelity Investments reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
Fidelity Investments sold 2 Ampio Pharmaceuticals Inc. shares in Q4 2023, an estimated $7.
Fidelity Investments first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 7 quarters.
Fidelity Investments's Ampio Pharmaceuticals Inc. position peaked at $2.19M in Q3 2013.
29 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.